Our interest is the molecular biology of human behaviour, which we aim to translate into improving etiological and therapeutic models of neuropsychiatric disorders. We have reported on the influence of genetic variations on: mental illness risk, brain function/structure and drug treatment response.
We are dedicated to: 1) understanding the role of oxytocin in social cognition, and its relevance to psychosis and autism; and 2) building clinically useful biomarkers for aiding clinical diagnostic and prognostic predictions. For this, we combine psychological and neuropharmacological experimentation with (epi)genetics, neuroimaging and psychophysiological tools – which is made possible by a diverse team of biomedical engineers, psychologists, biologists and psychiatrists.
Our Science Outreach
Want to Help Us (PT only)?